CENCORA, INC. for CENCORA, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Repeal of LIFO (last in, first out).
| Lobbyist | Covered position, as disclosed |
|---|---|
| RITA E NORTON | — |
| BRADFORD TALLAMY New | — |
Medicare/Medicaid MMM
H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RITA E NORTON | — |
| BRADFORD TALLAMY New | — |
Pharmacy PHA
H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmicist services
| Lobbyist | Covered position, as disclosed |
|---|---|
| RITA E NORTON | — |
| BRADFORD TALLAMY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.